DEPO - Depomed Stock Price - Barchart.com Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of … DEPO - TheStreet Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Profile Depomed MORE. Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central
- DEPO - Stock Price Today - Zacks View %COMPANY_NAME% DEPO investment & stock information. Get the latest %COMPANY_NAME% DEPO detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Stock Quote | Assertio Therapeutics, Inc. The Investor Relations website contains information about Assertio Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts. Stocks On the Move: Depomed Inc, Interpace Diagnostics ... Jan 03, 2017 · Buoying the stock is a New York Post report, claiming KKR & Co. L.P. (NYSE:KKR) is interested in buying the drugmaker. Suffice it to say, Depomed Inc … Assertio Therapeutics, Inc. SC 14D9/A Nov 4 2015 | Seeking ...
Jan 01, 2010 · Depomed, Inc. (NASDAQ: DEPO) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga.
Depomed Inc. Announces Corporate Name Change to Assertio ...
Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything we do; with a focus on enhancing the lives of patients, families, physicians, providers
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. ASRT Stock Price, Forecast & News (Depomed) | MarketBeat The company sells its products to wholesalers and retail pharmacies. The company was formerly known as Depomed Inc. and changed its name to Assertio Therapeutics, Inc. in August 2018 Assertio Therapeutics, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois.
Sep 16, 2016 · Depomed Inc (NASDAQ: DEPO) stock was up on Friday following reports that the company is considering a sale. Depomed is reportedly working with Morgan Stanley as …
The company sells its products to wholesalers and retail pharmacies. The company was formerly known as Depomed Inc. and changed its name to Assertio Therapeutics, Inc. in August 2018 Assertio Therapeutics, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois. DEPO Stock Quote of Depomed Inc - InvestorPlace
News about Depomed Inc., including commentary and archival articles published in The New York Times. 10 Mar 2020 The institutional investor bought 3.6 million shares of the stock in a Assertio Therapeutics Inc. (ASRT) shares are taking a pay cut of -81.42% 7 Mar 2018 Depomed (DEPO) has adopted a three-pronged business strategy with The mean rating for the stock is 2.71, with a target price of $8.43. Depomed, Inc. 1360 O'Brien Drive Menlo Park, CA 94025-1436. Tel: (866) 458- 6389. www.depomedinc.com. Drugs. CAMBIA. Migraine and headache.